tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LRMR Stock Latest News

Larimar Therapeutics Announces $64.4 Million Stock Offering
Company AnnouncementsLarimar Therapeutics Announces $64.4 Million Stock Offering
7d ago
8K
LRMR
Larimar Therapeutics 18.75M share Spot Secondary priced at $3.20
PremiumThe Fly
Larimar Therapeutics 18.75M share Spot Secondary priced at $3.20
8d ago
LRMR
Larimar Therapeutics TBA Spot Secondary; price range $3.20-$3.40
PremiumThe Fly
Larimar Therapeutics TBA Spot Secondary; price range $3.20-$3.40
8d ago
LRMR
Larimar Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Larimar Therapeutics announces common stock offering, no amount given
8d ago
LRMR
Promising Potential of Larimar Therapeutics’ Nomlabofusp in Friedreich’s Ataxia: A Buy Rating Justified
PremiumRatings
Promising Potential of Larimar Therapeutics’ Nomlabofusp in Friedreich’s Ataxia: A Buy Rating Justified
27d ago
LRMR
Positive Outlook for Larimar Therapeutics: Promising Data on Nomlabofusp and Anticipated Catalysts Drive Buy Rating
PremiumRatingsPositive Outlook for Larimar Therapeutics: Promising Data on Nomlabofusp and Anticipated Catalysts Drive Buy Rating
29d ago
LRMR
Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA
Premium
The Fly
Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA
30d ago
LRMR
Promising Regulatory Progress and Market Potential for Larimar Therapeutics
Premium
Ratings
Promising Regulatory Progress and Market Potential for Larimar Therapeutics
1M ago
LRMR
Larimar Therapeutics price target lowered to $15 from $17 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target lowered to $15 from $17 at Wedbush
1M ago
LRMR
Larimar Therapeutics selloff a buying opportunity, says Citi
PremiumThe Fly
Larimar Therapeutics selloff a buying opportunity, says Citi
1M ago
LRMR
Larimar Therapeutics Updates on Nomlabofusp Progress
PremiumCompany Announcements
Larimar Therapeutics Updates on Nomlabofusp Progress
1M ago
8K
LRMR
Larimar Therapeutics: FDA Guidance Boosts Buy Rating Amid Promising Regulatory Progress
PremiumRatings
Larimar Therapeutics: FDA Guidance Boosts Buy Rating Amid Promising Regulatory Progress
1M ago
LRMR
Larimar Therapeutics Receives FDA Guidance for BLA Submission
PremiumCompany AnnouncementsLarimar Therapeutics Receives FDA Guidance for BLA Submission
1M ago
8K
LRMR
Larimar announces FDA safety database recommendations for nomlabofusp BLA
Premium
The Fly
Larimar announces FDA safety database recommendations for nomlabofusp BLA
1M ago
LRMR
Larimar to trade down on delayed FDA submission, says JonesResearch
Premium
The Fly
Larimar to trade down on delayed FDA submission, says JonesResearch
1M ago
LRMR
Larimar Therapeutics Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Larimar Therapeutics Holds 2025 Annual Stockholders Meeting
3M ago
8K
LRMR
Larimar Therapeutics Advances Nomlabofusp Amid Financial Loss
PremiumCompany Announcements
Larimar Therapeutics Advances Nomlabofusp Amid Financial Loss
3M ago
LRMR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ATOS
CYCC
Optimistic Buy Rating for Larimar Therapeutics Amid Promising Phase II Study and Regulatory Progress
PremiumRatings
Optimistic Buy Rating for Larimar Therapeutics Amid Promising Phase II Study and Regulatory Progress
3M ago
LRMR
Buy Rating for Larimar Therapeutics Driven by Regulatory Progress and FDA Support
PremiumRatingsBuy Rating for Larimar Therapeutics Driven by Regulatory Progress and FDA Support
3M ago
LRMR
Larimar Therapeutics reports Q1 EPS (46c), consensus (41c)
Premium
The Fly
Larimar Therapeutics reports Q1 EPS (46c), consensus (41c)
3M ago
LRMR
Larimar Therapeutics sees cash runway into 2Q26
Premium
The Fly
Larimar Therapeutics sees cash runway into 2Q26
3M ago
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >